Literature DB >> 4040216

Effects of discriminant and non-discriminant dopamine antagonists on in vivo accumulation of 3H-N-propyl-norapomorphine in mouse striatum and tuberculum olfactorium.

C Gulat-Marnay, A Lafitte, J C Schwartz, P Protais.   

Abstract

The in vivo accumulation of 3H-N-propyl norapomorphine in mouse striatum and tuberculum olfactorium and its inhibition by a series of classical neuroleptics and discriminant benzamide derivatives previously identified in behavioural and radioligand experiments has been studied. The ID50 values in the two brain areas did not significantly differ with any studied compound. In addition the regional distribution of a discriminant compound related to sulpiride and administered in tritiated form to rats was rather homogeneous. These data do not indicate a preferential accumulation of these compounds in limbic as opposed to striatal areas.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4040216     DOI: 10.1007/bf00501199

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  23 in total

Review 1.  Multiple receptors for dopamine.

Authors:  J W Kebabian; D B Calne
Journal:  Nature       Date:  1979-01-11       Impact factor: 49.962

2.  Spiperone: a ligand of choice for neuroleptic receptors. 2. Regional distribution and in vivo displacement of neuroleptic drugs.

Authors:  P M Laduron; P F Janssen; J E Leysen
Journal:  Biochem Pharmacol       Date:  1978-02-01       Impact factor: 5.858

3.  Classification of neuroleptic drugs according to their ability to inhibit apomorphine-induced locomotion and gnawing: evidence for two different mechanisms of action.

Authors:  T Ljungberg; U Ungerstedt
Journal:  Psychopharmacology (Berl)       Date:  1978-04-11       Impact factor: 4.530

4.  In vivo binding of 3H-pimozide in mouse striatum: effects of dopamine agonists and antagonists.

Authors:  M Baudry; M P Martres; J C Schwartz
Journal:  Life Sci       Date:  1977-10-15       Impact factor: 5.037

5.  Differential labelling of dopamine receptors in rat brain in vivo: comparison of [3H]piribedil, [3H]S 3608 and [3H]N,n-propylnorapomorphine.

Authors:  M D Hall; P Jenner; C D Marsden
Journal:  Eur J Pharmacol       Date:  1983-01-28       Impact factor: 4.432

6.  Unexpected potentiation by discriminant benzamide derivatives of stereotyped behaviours elicited by dopamine agonists in mice.

Authors:  M Vasse; P Protais; J Costentin; J C Schwartz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-04       Impact factor: 3.000

7.  Dopaminergic binding sites in rat striatal slices and the action of guanyl nucleotides.

Authors:  M P Martres; P Sokoloff; J C Schwartz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-02       Impact factor: 3.000

8.  Regional in vivo binding of [3H]N-propylnorapomorphine in the mouse brain. Evidence for labelling of central dopamine receptors.

Authors:  C Köhler; K Fuxe; S B Ross
Journal:  Eur J Pharmacol       Date:  1981-07-10       Impact factor: 4.432

9.  Differential anatomical location of [3H]-N,n-propylnorapomorphine and [3H]-spiperone binding sites in the striatum and substantia nigra of the rat.

Authors:  M D Hall; P Jenner; E Kelly; C D Marsden
Journal:  Br J Pharmacol       Date:  1983-06       Impact factor: 8.739

10.  3H-Dopamine binding sites differ in rat striatum and pituitary.

Authors:  P Sokoloff; M P Martres; M Delandre; K Redouane; J C Schwartz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-09       Impact factor: 3.000

View more
  3 in total

1.  Differences in the time course of dopaminergic supersensitivity following chronic administration of haloperidol, molindone, or sulpiride.

Authors:  E S Prosser; R Pruthi; J G Csernansky
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

2.  Unexpected potentiation by discriminant benzamide derivatives of stereotyped behaviours elicited by dopamine agonists in mice.

Authors:  M Vasse; P Protais; J Costentin; J C Schwartz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-04       Impact factor: 3.000

3.  3H-(-)DO 710 discriminates guanine nucleotide sensitive and insensitive dopamine binding sites.

Authors:  P Sokoloff; K Redouane; M Brann; M P Martres; J C Schwartz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-05       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.